Home/Filings/4/0000874015-25-000120
4//SEC Filing

Birchler Brian 4

Accession 0000874015-25-000120

CIK 0000874015other

Filed

Apr 16, 8:00 PM ET

Accepted

Apr 17, 4:53 PM ET

Size

8.9 KB

Accession

0000874015-25-000120

Insider Transaction Report

Form 4
Period: 2025-04-15
Birchler Brian
EVP, Corp and Development Ops
Transactions
  • Sale

    Common Stock

    2025-04-16$28.37/sh680$19,29256,660 total
  • Exercise/Conversion

    Common Stock

    2025-04-15+1,87557,340 total
  • Exercise/Conversion

    Restricted Stock Unit

    2025-04-151,87561,215 total
    Exercise: $0.00From: 2025-04-15Common Stock (1,875 underlying)
Footnotes (4)
  • [F1]Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award.
  • [F2]The sale was made pursuant to an automatic sale to cover the required tax withholding obligations pursuant to the 2011 Equity Incentive Plan Restricted Stock Unit Agreement and Grant Notice.
  • [F3]Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value.
  • [F4]Restricted Stock Units vest in four equal annual installments. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company.

Issuer

IONIS PHARMACEUTICALS INC

CIK 0000874015

Entity typeother

Related Parties

1
  • filerCIK 0001970151

Filing Metadata

Form type
4
Filed
Apr 16, 8:00 PM ET
Accepted
Apr 17, 4:53 PM ET
Size
8.9 KB